OxiGene (OXGN)

Add to Watchlists
Create an Alert
1.18 +0.00  +0.00% NASDAQ Aug 31, 17:00 Delayed 2m USD
View Full Chart
OXGN Price Chart
View All Events

OXGN Events

Date Type Description
08/04/2015 13:30 EDT Misc OxiGene Inc Second Quarter Earnings Conference Call in 2015
08/04/2015 Earnings OxiGene Inc Second Quarter Earnings in 2015 Release
04/30/2015 16:30 EDT Misc OxiGene Inc First Quarter Earnings Results in 2015
04/30/2015 Earnings OxiGene Inc First Quarter Earnings Results in 2015 Release
04/15/2015 15:00 EDT Misc OXIGENE ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR AND MEDICAL CONFERENCES
03/17/2015 16:30 EDT Misc OxiGene Inc Fourth Quarter Earnings Conference Call in 2014
03/17/2015 Earnings OxiGene Inc Fourth Quarter Earnings in 2014 Release
11/12/2014 16:30 EDT Misc OxiGene Announces Third Quarter 2014 Earnings Conference Call and Webcast
11/12/2014 Earnings OXIGENE ANNOUNCES THIRD QUARTER 2014 EARNINGS RELEASE
View All Performance Charts

OXGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OxiGene is down 48.25% over the last year vs S&P 500 Total Return up 0.82%, Synthetic Biologics up 8.48%, and TG Therapeutics up 43.86%.

Advertisement

OXGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.oxigene.com
  • IR Website: http://investor.oxigene.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: June 30, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

OxiGene Inc is a biopharmaceutical company. The Company is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer. It has two clinical stage product candidates that are developed in three potential oncology indications.

OXGN Excel Add-In Codes

  • Name: =YCI("OXGN","name")
  • Description: =YCI("OXGN","description")
  • Sector: =YCI("OXGN","sector")
  • Industry: =YCI("OXGN","industry")
  • Est. Current Fiscal Year End: =YCI("OXGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.